Can an app plus nicotine gum help hispanic smokers kick the habit?

NCT ID NCT06811038

Not yet recruiting Disease control Sponsor: Fred Hutchinson Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This phase III trial will enroll 854 Hispanic adults who smoke and want to quit. Participants will use the iCanQuit smartphone app, which teaches skills to manage cravings and prevent relapse. Half will also receive nicotine replacement therapy (gum, patch, or lozenge) to ease withdrawal. The study aims to see if adding NRT boosts quit rates compared to the app alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Nicotine replacement therapy (gum, patch, lozenge) and a smartphone app (iCanQuit)
What this could lead to: If successful, this could provide an effective, scalable smoking cessation program tailored for Hispanic adults, reducing smoking-related diseases.
What could go wrong: This is a large trial, but results depend on participants sticking with the app and NRT. The benefit may be modest, and long-term abstinence is hard to maintain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIGARETTE SMOKING-RELATED CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

squamous cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CIGARETTE SMOKING-RELATED CARCINOMA

Contacts and locations

Locations

Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington, 98109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.